NFKB1 and autoimmune disease: TRIM22 is an interferon-induced protein that potently inhibits the replication of diverse viruses such as HIV-1 [23], HCV [15, 25] and HBV [26]; and the overexpression of TRIM22 activates NF-κB in a dose-dependent manner [41], promoting autoimmune diseases [42].